Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Elekta shares jump 11% after Q2 margin beat despite weak orders (Investing.com) +++ ELEKTA Aktie +5,09%

ELEKTA Aktie

 >ELEKTA Aktienkurs 
4.442 EUR    +9.6%    (Tradegate)
Ask: 4.464 EUR / 3400 Stück
Bid: 4.43 EUR / 3400 Stück
Tagesumsatz: 4050 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
ELEKTA Aktie über LYNX handeln
>ELEKTA Performance
1 Woche: +3,2%
1 Monat: -13,0%
3 Monate: -7,9%
6 Monate: -9,9%
1 Jahr: -27,6%
laufendes Jahr: -23,2%
>ELEKTA Aktie
Name:  ELEKTA AB B SK 2
Land:  Schweden
Sektor:  Gesundheit
ISIN/ Wkn:  SE0000163628 / 896279
Symbol/ Ticker:  EJXB (Frankfurt)
Kürzel:  FRA:EJXB, ETR:EJXB, EJXB:GR
Index:  -
Webseite:  http://www.elekta.com/
Profil:  Elekta AB is a leading provider of precision radia..
>Volltext..
Marktkapitalisierung:  1495.86 Mio. EUR
Unternehmenswert:  1941.39 Mio. EUR
Umsatz:  1567.56 Mio. EUR
EBITDA:  242.37 Mio. EUR
Nettogewinn:  23.99 Mio. EUR
Gewinn je Aktie:  0.06 EUR
Schulden:  680.09 Mio. EUR
Liquide Mittel:  242.54 Mio. EUR
Operativer Cashflow:  266.62 Mio. EUR
Bargeldquote:  0.22
Umsatzwachstum:  2.22%
Gewinnwachstum:  -75.03%
Dividende je Aktie:  0.22 EUR
Dividendenrendite:  5.52%
Dividendenschätzung:  5.52%
Div. Historie:  05.09.25 - 0.108456€
06.03.25 - 0.108456€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  ELEKTA
Letzte Datenerhebung:  26.11.25
>ELEKTA Kennzahlen
Aktien/ Unternehmen:
Aktien: 367.1 Mio. St.
Frei handelbar: 97.99%
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: 4556
Umsatz/Mitarb.: 0.35 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 18.9%
Bewertung:
KGV: 63.24
KGV lG: 13.23
KUV: 0.91
KBV: 1.91
PEG-Ratio: -
EV/EBITDA: 8.01
Rentabilität:
Bruttomarge: 37.41%
Gewinnmarge: 1.53%
Operative Marge: 12.06%
Managementeffizenz:
Gesamtkaprendite: 0.9%
Eigenkaprendite: 2.76%
>ELEKTA Peer Group

Es sind 149 Aktien bekannt.
 
26.11.25 - 09:48
Elekta shares jump 11% after Q2 margin beat despite weak orders (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
05.09.25 - 21:09
XFRA: DIVIDEND/INTEREST INFORMATION - 05.09.2025 - SE0000163628 (XETRA)
 
Das Instrument EJXB SE0000163628 ELEKTA AB B SK 2 EQUITY wird ex Dividende/Zinsen gehandelt am 05.09.2025 The instrument EJXB SE0000163628 ELEKTA AB B SK 2 EQUITY has its ex-dividend/interest day on 05.09.2025...
03.09.25 - 14:01
UBS initiates Elekta at “sell,” cites slowing radiotherapy market and 30% downside (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
29.08.25 - 11:06
Johan Andersson appointed new head of Investor Relations (Cision)
 
Saab has appointed Johan Andersson as the new head of Investor Relations. He will assume his position on September 15, 2025. Johan Andersson has more than 15 years of experience in investor relations and most recently held the role of head of IR at Husqvarna Group. He has previously held senior positions at companies such as SCA, Securitas Systems and Elekta. “I am pleased and proud to be joining Saab in the midst of the company's strong growth journey. I look forward to contributing to an open and constructive dialogue with our investors, and to highlighting the company's long-term value...
28.08.25 - 15:03
Elekta AB reports FQ1 results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.08.25 - 08:57
Elekta Q1 profit jumps 50% as cash flow strengthens despite sales drop (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
30.07.25 - 15:48
Novo Nordisks stock plunge isnt surprising. Why companies clear the deck for new CEOs (CNBC)
 
Renault, Elekta, Tietoevry and a number of others have recently reset expectations with investors....
07.07.25 - 13:01
Elekta and Gray partner to offer optimized oncology appointment scheduling for Elekta ONE OIS customers (PR Newswire)
 
MONTRÉAL, July 7, 2025 /PRNewswire/ - Gray Oncology Solutions, Inc. (Gray), a Montréal-based technology company, today announced that it has partnered with Elekta to offer its Care Orchestration Platform, GrayOS, to Elekta ONE OIS customers. Serving as a logistics layer, GrayOS uses an......
01.07.25 - 08:54
Gradientech appoints Veronica Byfield Sköld to Board of Directors (Cision)
 
The diagnostics company Gradientech today announces the appointment of Veronica Byfield Sköld to its Board of Directors, effective May 21, 2025. Following her appointment, the Board now comprises six directors. Veronica Byfield Sköld brings over 25 years of experience in international medtech and life sciences. She has held senior commercial roles at companies including Elekta and Permobil, and served as CEO of the biotech company BioLamina until 2024. Her previous experience also includes positions at Boston Consulting Group (BCG), Gambro, and as Partner at the private equity firm Impilo,...
19.06.25 - 17:12
Fuse Oncology Announces Partnership With Elekta (PR Newswire)
 
Industry vendors team up to support radiation oncology clinics nationwide BOONE, N.C., June 19, 2025 /PRNewswire/ -- Fuse Oncology, an oncology healthcare software solutions provider, today announces its partnership with Elekta, a leading innovator of precision radiation therapy solutions.......
10.06.25 - 13:36
Elekta shares down after SEK 4.9 bln order cancellation; new CEO appointed (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
28.05.25 - 08:54
Elekta AB GAAP EPS of -SEK 1.01, revenue of SEK 5.16B; initiates Q1 outlook (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.05.25 - 08:12
Elekta′s net income plunges 82% in fiscal 2024-25 despite sales growth (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
12.03.25 - 15:12
White Pearl Technology Group AB Appoints Peter Ejemyr as Vice President Investor Relations (Cision)
 
White Pearl Technology Group AB (Nasdaq First North: WPTGB, OTC: WPTGF) today announced the appointment of Peter Ejemyr as Vice President Investor Relations. This newly created position, based in Stockholm, strengthens the company's executive team and underscores WPTG's commitment to enhancing investor communications. Ejemyr brings extensive investor relations experience to WPTG, having previously held senior IR positions at prominent Swedish companies, including Elekta AB and Biacore AB.  Marco Marangoni, CEO of White Pearl Technology Group, commented: "The creation of this dedicated VP...
21.02.25 - 11:42
Elekta shares tumble as company lowers full-year outlook (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
21.02.25 - 10:36
Elekta AB reports Q3 results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.01.25 - 14:48
Bernstein upgrades Coloplast, Elekta; Philips still top pick (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
10.01.25 - 13:31
Åsa Thunman new General Counsel and part of the Skanska Group Leadership Team (Cision)
 
Åsa Thunman has been appointed as General Counsel and Executive Vice President at Skanska Group. She will take on her new position no later than July 8, 2025, and at the same time become part of the Skanska Group Leadership Team. Åsa Thunman comes from a position as General Counsel at Sandvik. She has held key legal and executive roles in multinational companies, including Sandvik, Securitas, and Elekta. In her new role she will report to Anders Danielsson, CEO and President, Skanska Group. “Åsa Thunman's broad, multinational legal and governance expertise across various industries along...
29.11.24 - 15:40
FDA Says Elekta Recalls Disposable Biopsy Needle Kits (Reuters EN)
 
BRIEF-FDA Says Elekta Recalls Disposable Biopsy Needle Kits Nov 29 (Reuters) - FDA: FDA: ELEKTA REMOVES DISPOSABLE BIOPSY NEEDLE KITS DUE TO RISK OF MICROSCOPIC STAINLESS STEEL DEBRIS INSIDE NEEDLE FDA: IDENTIFIED ELEKTA'S BIOPSY NEEDLE RECALL AS THE MOST SERIOUS TYPE -WEBSITE...
27.11.24 - 13:12
Elekta AB GAAP EPS of $0.63, revenue of SEK4.34B beats by SEK3.93B (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wenn alle kahlköpfig sind, ist es sehr schwer, ein Haar in der Sippe zu finden. - Dr. Fritz P. Rinnhofer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!